Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 7
2006 4
2007 4
2008 16
2009 9
2010 24
2011 18
2012 16
2013 18
2014 11
2015 3
2016 7
2017 9
2018 5
2019 14
2020 10
2021 4
2022 10
2023 12
2024 8
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: papadimitriou c. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote I, Pérez-Fidalgo JA, Hamilton EP, Valabrega G, Van Gorp T, Sehouli J, Cibula D, Levy T, Welch S, Richardson DL, Guerra EM, Scambia G, Henry S, Wimberger P, Miller DS, Klat J, Martínez-Garcia J, Raspagliesi F, Pothuri B, Romero I, Bergamini A, Slomovitz B, Schochter F, Høgdall E, Fariñas-Madrid L, Monk BJ, Michel D, Kauffman MG, Shacham S, Mirza MR, Makker V; ENGOT-EN5/GOG-3055/SIENDO Investigators. Vergote I, et al. J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5. J Clin Oncol. 2023. PMID: 37669480 Clinical Trial.
Neuroscience Needs Network Science.
Barabási DL, Bianconi G, Bullmore E, Burgess M, Chung S, Eliassi-Rad T, George D, Kovács IA, Makse H, Nichols TE, Papadimitriou C, Sporns O, Stachenfeld K, Toroczkai Z, Towlson EK, Zador AM, Zeng H, Barabási AL, Bernard A, Buzsáki G. Barabási DL, et al. Among authors: papadimitriou c. J Neurosci. 2023 Aug 23;43(34):5989-5995. doi: 10.1523/JNEUROSCI.1014-23.2023. J Neurosci. 2023. PMID: 37612141 Free PMC article.
Neuroscience needs Network Science.
Barabási DL, Bianconi G, Bullmore E, Burgess M, Chung S, Eliassi-Rad T, George D, Kovács IA, Makse H, Papadimitriou C, Nichols TE, Sporns O, Stachenfeld K, Toroczkai Z, Towlson EK, Zador AM, Zeng H, Barabási AL, Bernard A, Buzsáki G. Barabási DL, et al. Among authors: papadimitriou c. ArXiv [Preprint]. 2023 May 11:arXiv:2305.06160v2. ArXiv. 2023. Update in: J Neurosci. 2023 Aug 23;43(34):5989-5995. doi: 10.1523/JNEUROSCI.1014-23.2023. PMID: 37214134 Free PMC article. Updated. Preprint.
Sex: The power of randomization.
Vasylenko L, Feldman MW, Papadimitriou C, Livnat A. Vasylenko L, et al. Among authors: papadimitriou c. Theor Popul Biol. 2019 Oct;129:41-53. doi: 10.1016/j.tpb.2018.11.005. Epub 2019 Jan 9. Theor Popul Biol. 2019. PMID: 30638926
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer.
Rimel BJ, Pujade-Lauraine E, Moore K, Pfisterer J, Han S, Cibula D, Reyners A, Redondo A, Papadimitriou C, Eitan R, Pignata S, Glasspool R, Mirza MR, Bodnar L, Duska L, Provencher D, Phaëton R, Bains M, Coskuncay E, Hardy-Bessard AC. Rimel BJ, et al. Among authors: papadimitriou c. Oncologist. 2025 Oct 1;30(10):oyaf270. doi: 10.1093/oncolo/oyaf270. Oncologist. 2025. PMID: 40973032 Free PMC article. Review.
Brain computation by assemblies of neurons.
Papadimitriou CH, Vempala SS, Mitropolsky D, Collins M, Maass W. Papadimitriou CH, et al. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14464-14472. doi: 10.1073/pnas.2001893117. Epub 2020 Jun 9. Proc Natl Acad Sci U S A. 2020. PMID: 32518114 Free PMC article.
An impossibility theorem in game dynamics.
Milionis J, Papadimitriou C, Piliouras G, Spendlove K. Milionis J, et al. Among authors: papadimitriou c. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2305349120. doi: 10.1073/pnas.2305349120. Epub 2023 Oct 5. Proc Natl Acad Sci U S A. 2023. PMID: 37796988 Free PMC article.
The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory.
Tsoulos N, Agiannitopoulos K, Potska K, Katseli A, Ntogka C, Pepe G, Bouzarelou D, Papathanasiou A, Grigoriadis D, Tsaousis GN, Gogas H, Troupis T, Papazisis K, Natsiopoulos I, Venizelos V, Amarantidis K, Giassas S, Papadimitriou C, Fountzilas E, Stathoulopoulou M, Koumarianou A, Xepapadakis G, Blidaru A, Zob D, Voinea O, Özdoğan M, Ergören MÇ, Hegmane A, Papadopoulou E, Nasioulas G, Markopoulos C. Tsoulos N, et al. Among authors: papadimitriou c. Cancer Genomics Proteomics. 2024 Sep-Oct;21(5):448-463. doi: 10.21873/cgp.20463. Cancer Genomics Proteomics. 2024. PMID: 39191493 Free PMC article.
The Role of EMT-Related lncRNAs in Ovarian Cancer.
Lampropoulou DI, Papadimitriou M, Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G, Gazouli M. Lampropoulou DI, et al. Among authors: papadimitriou c. Int J Mol Sci. 2023 Jun 13;24(12):10079. doi: 10.3390/ijms241210079. Int J Mol Sci. 2023. PMID: 37373222 Free PMC article. Review.
197 results